Peking University First Hospital: clinical-trial pipeline
Peking University First Hospital is the sponsor of 386 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 165 are not yet finished and 8 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 254 |
| Phase 4 | 77 |
| Phase 2 | 24 |
| Phase 1 | 13 |
| Early phase 1 | 6 |
| Phase 2/3 | 5 |
| Phase 1/2 | 4 |
| Phase 3 | 3 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 122 |
| Recruiting | 102 |
| Unknown | 83 |
| Not yet recruiting | 49 |
| Active, not recruiting | 14 |
| Terminated | 11 |
| Withdrawn or not authorised | 4 |
| Suspended or halted | 1 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 117 |
| Nephrology and urology | 109 |
| Cardiovascular | 48 |
| Infectious disease and vaccines | 24 |
| Gastroenterology and liver | 20 |
| Metabolic and endocrine (diabetes, obesity) | 17 |
| Women's health and obstetrics | 17 |
| Musculoskeletal | 16 |
| Rare and genetic diseases | 13 |
| Neurology | 12 |
| Psychiatry and mental health | 12 |
| Respiratory | 11 |
Countries
| Country | Trials |
|---|---|
| China | 339 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-15 | New trial posted | BBM-L101 Gene Therapy in Participants With LGMD2D/R3 |
| 2026-10-15 | New trial posted | 68Ga- and 18F-CAIX PET Imaging Study |
| 2026-10-15 | New trial posted | 18F-N230A PET/CT Imaging of Nectin-4 Expression in Renal Tumors |
| 2026-10-06 | New trial posted | Combination of Rituximab and Cyclosporine in the Treatment of Primary Membranous Nephropa… |
| 2026-10-02 | New trial posted | A Prospective Clinical Study of Zeprumetosta in Patients With Relapsed or Refractory Cuta… |
| 2026-09-30 | New trial posted | Efficacy Evaluation of Modified Zhixiao Tongmai Ning in Preventing Radiation-Induced Kidn… |
| 2026-09-14 | New trial posted | Proton and Proton-Photon Hybrid Partial Stereotactic Ablative Boost Radiotherapy (P-SABR)… |
| 2026-08-31 | New trial posted | GPC3-Targeted PET Imaging of 18F-X12 in Hepatocellular Carcinoma |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT07508852 | 68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer | Phase 1/2 | Recruiting | China |
| NCT07525986 | Anrikefon-based Patient-controlled Intravenous Analgesia Following Laparoscopic Surgery | Phase 4 | Recruiting | China |
| NCT07007286 | Real-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancer | Not applicable | Not yet recruiting | China |
| NCT07504939 | Multimodal Kidney-Sparing Strategy for High-Risk Upper Tract Urothelial Carcinoma | Not applicable | Not yet recruiting | China |
| NCT07849088 | Efficacy Evaluation of Modified Zhixiao Tongmai Ning in Preventing Radiation-Induced Kidney Injury | Phase 2 | Recruiting | China |
| NCT07660939 | GPRC5D Targeted PET/CT Imaging in Plasma Cell Disorders | Phase 1 | Recruiting | China |
| NCT06062550 | Different Dose Esketamine and Dexmedetomidine Combination for Supplemental Analgesia After Scoliosis Correcti… | Phase 4 | Active, not recruiting | China |
| NCT07479602 | Intranasal Dexmedetomidine-esketamine Administration and Postoperative Pain in Pediatric Patients | Phase 4 | Recruiting | China |
| NCT07523334 | Impact of Esketamine on Delayed Neurocognitive Recovery in Older Patients | Phase 4 | Not yet recruiting | China |
| NCT07795437 | GPC3-Targeted PET Imaging of 18F-X12 in Hepatocellular Carcinoma | Not applicable | Recruiting | China |
| NCT07479719 | Anesthesia Maintenance With Target-controlled Infusion of Propofol and Remifentanil at Fixed Ratio | Phase 4 | Not yet recruiting | China |
| NCT07818798 | Proton and Proton-Photon Hybrid Partial Stereotactic Ablative Boost Radiotherapy (P-SABR) for Unresectable La… | Not applicable | Not yet recruiting | |
| NCT07015138 | Comprehensive Versus Primary Tumor Radiotherapy in Oligometastatic Prostate Cancer | Not applicable | Recruiting | China |
| NCT05683353 | Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic Tumors | Not applicable | Active, not recruiting | China |
| NCT07643792 | Fascia Iliaca Block Using Liposomal Bupivacaine for Analgesia After Hip Surgery | Phase 4 | Not yet recruiting | China |
| NCT06793163 | Diagnosis and Allergen Identification of Perioperative Anaphylaxis | Not applicable | Recruiting | China |
| NCT07046364 | Remimazolam and Emergence Delirium in Pediatrics | Phase 4 | Recruiting | China |
| NCT06889649 | SABR Combined with Axitinib and Toripalimab in Recurrent or Metastatic RCC | Phase 2 | Recruiting | China |
| NCT06669429 | A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RS-C1001 Tablets in Chinese Hea… | Phase 1 | Recruiting | China |
| NCT06924359 | Multimodal Ophthalmic Imaging and Plasma Biomarkers for the Early Detection of Alzheimer's Disease | Not applicable | Recruiting | China |
| NCT07100184 | RC48 in Combination With Radiotherapy for HER2-Expressing NMIBC Patients | Phase 2 | Not yet recruiting | |
| NCT06991868 | A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of… | Not applicable | Recruiting | China |
| NCT07468474 | Establishment of Screening Pathway for High-Risk Population of Type 1 Diabetes | Not applicable | Recruiting | China |
| NCT06392737 | Comparison of MRI Artificial Intelligence-guided cTB Versus Routine cTB in Prostate Cancer Diagnosis | Not applicable | Recruiting | China |
| NCT07597369 | Clinically Actionable Tumor-Associated Antigens in Prostate Cancer | Not applicable | Active, not recruiting | China |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Peking University First Hospital clinical trials: 165 open, 8 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/peking-university-first-hospital/, data as of 2026-10-25.